Allergic Rhinitis Treatment Market Will Cross US$ 7,000 Million by the end of 2024

“Technological advancements in the medical world and rising prevalence of foodborne diseases will primarily build the market for allergic rhinitis treatment globally. Secondarily, strategic partnerships and synergies between big brands, soaring usage of second-generation multiplex immunoassay, and augmenting R&D activities in life sciences and molecular diagnostics will support the market surge within the next few years. Over 2016-2020, the global AR treatment market will reach US$ 14 Bn, which will further take a leap to US$ 16.038 Bn by the end of 2024. Over 2016-2024, the market is likely to see impressive growth at a healthy CAGR of 7.5%.”

– Market Research Expert, Life Sciences & Transformational Health, Persistence Market Research.

Browse Full Research Report:

https://www.persistencemarketresearch.com/market-research/allergic-rhinitis-market.asp

According to Persistence Market Research’s recent report titled “Global Allergic Rhinitis Treatment Market: Industry Analysis and Forecast, 2016–2024,” key market competitors have embraced different strategic moves in order to strengthen their positions in the global allergic rhinitis treatment marketplace. These activities, according to Persistence Market Research, will boost the overall status of the market in near future.

  • Merck & Co. and Johnson & Johnson are concentrating on new product development, such as nasal sprays.

  • Boehringer Ingelheim will continue to contribute a major share to the market through an increased focus on R&D and a strong distribution network.

  • Sanofi S.A. is also focusing more on increasing R&D investments directed to expanded sales.

  • In addition to growing R&D efforts, AstraZeneca is also emphasizing on innovation of technologically advanced products and acquisition of selective regional players.

  • GlaxoSmithKline PLC and Alcon (Novartis AG) are prioritising cost-effective product development for long-term profits; Alcon specifically aims to tap into emerging markets.

  • Acquisition of players from the same segment and different region will be a key strategy of Teva Pharmaceutical Industries Ltd., which targets production capacity expansion.

Request and Download Sample Report@

https://www.persistencemarketresearch.com/samples/12154

By disease type, perennial AR segment will remain dominant with around 47% market value share in 2024, gaining around 123 BPS throughout the forecast period. On the other hand, despite losing over 30 BPS over 2016-2024, occupational AR will continue to be the second largest segment with over 35% revenue share at the end of the assessment period. While the revenues of the former are expected to surpass US$ 7.0 Bn, the latter will possibly exceed a value of US$ 5.0 Bn by the end of 2024.

By treatment type, immunotherapy treatment segment is expected to be the fastest growing segment over the forecast owing to introduction of new immunotherapy based products, followed by antihistamines segment. However, antihistamines will continue to be the leading treatment type segment with over 50% share in 2024, followed by corticosteroids with over 31% share.

Based on route of administration, oral route of administration segment will cover nearly half of the market in terms of value, whereas nasal route of administration segment is anticipated to capture around 38% share of the total market value in 2024. Intravenous segment is foreseen to witness a higher CAGR compared to others, which can uplift the sales revenues of this segment to cross US$ 1.25 Bn in 2024.

On the basis of distribution channel, retail pharmacies will account for higher revenues than hospital pharmacies throughout the assessed period. Retail pharmacy revenues are likely to surpass US$ 7.0 Bn, growing at the fastest CAGR of 3.9% over 2016-2024. Whereas, hospital pharmacies will reach over US$ 5.0 Bn, accounting for around 31% share of the market value in 2024.

As per the geographical assessment of the global allergic rhinitis treatment market, North America will continue to capture the maximum revenue share over the 10-year tenure. With over 63% value share by 2024-end, this region is likely to surpass US$ 10.0 Bn in terms of revenues. European market will possibly attract the revenues worth US$ 3.68 Bn by 2024 end, contributing over 22% share of the market size. The third key region i.e. APAC is estimated to reach over US$ 1.27 Bn in 2024.

Buy Full Allergic Rhinitis (AR) Treatment Market Report

@ https://www.persistencemarketresearch.com/checkout/12154

Advertisements

Hepatitis C Treatment Market Will Cross US$ 71.13 Billion by the end of 2024

Persistence Market Research (PMR) delivers key insights on the global hepatitis C treatment market in its latest report titled “Hepatitis C Treatment Market: Global Industry Analysis and Forecast, 2016–2024”. The global hepatitis C treatment market was valued at US$ 23.9 Bn in 2015 and is estimated to be valued at US$ 26.6 Bn by 2016. The market is expected to reach a valuation of US$ 71.13 Bn by the end of 2024, reflecting a CAGR of 13.1% over the forecast period.

Market dynamics

Growth of the global hepatitis C treatment market is primarily driven by factors such as increase in the prevalence of hepatitis C infections in the U.S. and Canada and rising per capita healthcare expenditure across the globe. Also government initiatives to control infection and various private NGOs creating awareness about treatment is also fueling the market growth. However, high cost associated with hepatitis C treatment drugs and lack of awareness about hepatitis C infection in the regions of Asia Pacific, Middle East and Africa, and Latin America is expected to impede growth of the global hepatitis C treatment market.

Browse Full Research Report:

https://www.persistencemarketresearch.com/market-research/hepatitis-c-treatment-market.asp

Market forecast

By drug class, the market is segmented into HCV Protease Inhibitors, HCV Polymerase Inhibitors, HCV NS5A Inhibitors, Combination Therapy and Interferon & Antiviral which is again sub-divided into various drugs sub segments. The combination segment is expected to contribute a maximum share to the global hepatitis C treatment market and register the fastest CAGR of 13.9% during the forecast period. By distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. Among these, the hospital pharmacies segment is anticipated to be dominant throughout the forecast period and is projected to account for about 43.7% share of the total global hepatitis C treatment market revenue by 2024. The hospital pharmacies segment is anticipated to emerge as the most attractive segment in the global hepatitis C treatment market owing to growing instances of hospitalization and improved accessibility and services. The online pharmacies segment is expected to register the fastest CAGR during the forecast period and is estimated to create absolute $ opportunity of US$ 713.8 Mn in 2017 over 2016. The online pharmacies segment is expected to witness significant growth during the forecast period and this can be attributed to high availability of hepatitis C treatment drugs and discounts provided by online pharmacies.

Request and Download Sample Report@

https://www.persistencemarketresearch.com/samples/3602

This report covers global and regional trends along with an analysis of the market potential. North America is estimated to account for 45% share in the global hepatitis C treatment market by 2016, whereas Asia Pacific is projected to grow at a healthy CAGR of 14.8% due to increasing awareness about hepatitis C infections. Europe region is expected to account for 19.6% share in the global hepatitis C treatment market by 2016 end. Latin America was valued at US$ 2,915.8 Mn in 2015 and is estimated to reach US$ 3,311.1 Mn by 2016, with a Y-o-Y growth of 13.6% over 2015–2016. The Middle East and Africa region was valued at US$ 1,792.5 Mn in 2015 and is estimated to reach US$ 1,988.1 Mn by 2016.

Competitive landscape

The global hepatitis C treatment market report features some of the top companies dominating in the global market. Key market players analyzed in the report include Merck & Co., Inc., Bristol-Myers Squibb Company, AbbVie Inc., Gilead Sciences, Inc., Kadmon Holdings, Inc., Johnson & Johnson, F Hoffmann-La Roche Ltd, and Merck & Co., Inc. Leading companies functioning in the global hepatitis C treatment market are focusing on collaborating with healthcare solutions and services providers in order to advance operational efficiencies and provide improved patient care.

Buy Full Hepatitis C Treatment Market Report

@ https://www.persistencemarketresearch.com/checkout/3602

Herpes Marker Testing Market Will Cross US$ 481.8 Million by the end of 2025

According to the latest market report published by Persistence Market Research titled ‘Herpes Marker Testing Market: Global Industry Analysis (2012 – 2016) & Forecast (2017 – 2025)’, the global market is expected to be valued at US$ 481.8 Mn by 2025 and expand at a CAGR of 6.1% over the forecast period (2017–2025). The overall market is anticipated to grow 1.7x in terms of value over the forecast period.

Market Dynamics

Certain factors such as positive diagnostic lab industry dynamics, increasing herpes prevalence, rising awareness, support from various government and non-government organizations, new product approvals and launches, increasing focus on evidence based medicines etc. are boosting revenue growth of the market. However, insufficient R&D initiatives, poor access to diagnostic services in remote areas, pricing pressures, and stringent regulations are some of the factors restricting growth of the market.

Browse Full Research Report:

https://www.persistencemarketresearch.com/market-research/herpes-markers-testing-market.asp

Segmental Forecast

On the basis of test type, the market has been segmented into viral culture test, nucleic acid amplification-based kits and antibody/antigen-based kits. Antibody/Antigen based kits is the highest revenue generating segment over the forecast period owing to the huge product availability as well as high physician preference for this test type. Nucleic Acid Amplification-based kits segment will report the highest growth rate over the forecast period due to the growing acceptance of PCR diagnosis as a gold standard test in herpes testing owing to high sensitivity, specificity and positivity ratio for herpes diagnosis. Antibody/Antigen based kits is projected to be the most attractive segment with an attractiveness index of 1.5 during the forecast period.

Based on the indication, the market has been segmented into HSV-1, HSV-2 and HSV-1/ HSV-2. HSV-1/HSV-2 segment dominated the global herpes marker testing market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. HSV-1/HSV-2 is projected to be the most attractive segment with an attractiveness index of 1.6 and growth rate of 6.5% during the forecast period.

On the basis of application, the market has been segmented into research use and clinical diagnostics segment. Clinical diagnostics application dominates the market for herpes marker testing with a value share in excess of 85% throughout the forecast period.

Request and Download Sample Report@

https://www.persistencemarketresearch.com/samples/4185

Based on end user, the market has been segmented into hospitals, diagnostics centers, clinics and academic & research institutes. Among all the end users, most of the revenue is generated via the diagnostic centers sales followed by hospitals owing to the maximum number of tests being performed at these facilities. Diagnostics centers dominated the global herpes marker testing market in revenue terms in 2016 and is projected to continue to do so throughout the forecast period. This segment represents a market attractiveness index of 1.6 over the forecast period.

Among the regional markets, North America holds the maximum value share in the global market owing to the accessibility and affordability of diagnostic services in the region and a favorable reimbursement scenario. In terms of growth rate, North America leads with a CAGR of 6.4% followed by Asia Pacific with a CAGR of 6.3%. Asia Pacific represents a highly potential market with a significant growth rate owing to the increasing awareness as well as increasing penetration of market players in the region. The market in Europe ranks third in terms of global market size as well as growth rate while Latin America represents the least market attractiveness index over the forecast period.

Vendor Insights

Leading players operating in the global herpes marker testing market covered in the report include Abbott Laboratories, Abcam Plc, BioMérieux SA, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Merck KGaA, Qiagen N.V., Norgen Biotek Corp., Hologic Inc., Bio Rad Laboratories Inc., Meridian Bioscience Inc. and Teco Diagnostics.

Buy Full Herpes Marker Testing Market Report 

@ https://www.persistencemarketresearch.com/checkout/4185

Medical X-ray detectors Market Will Cross US$ 3.3 Billion by the end of 2025

Increasing private and public investment in digital imaging technology particularly in the field of healthcare, the numerous benefits offered by digital detectors, analog X-ray reimbursement cuts, and reducing prices are the main factors driving the medical X-ray detectors market. Furthermore, technological advancements coupled with strong encouragement by venture capitalists should boost the medical X-ray detectors market throughout the course of the study period. The medical X-ray detectors market is poised to grow with a robust CAGR of 6.1% from 2017-2022.

Browse Full Research Report:

https://www.persistencemarketresearch.com/market-research/medical-x-ray-detectors-market.asp

Digital X-ray systems are twice the size of retrofit X-ray systems in terms of module type and are expected to become even more popular in the days ahead. The digital x-ray systems medical X-ray detectors segment is on track to be worth more than US$ 2 billion by the end of the study period, making it imperative for key stakeholders to target this segment. Retrofit systems are slowly but surely fading in popularity. Nonetheless, this segment still accounts for a revenue share approaching a third of the medical X-ray detectors market in 2017 and companies cannot overlook it entirely in favor of digital x-ray systems.

Fixed detectors comprise more than half the medical X-ray detectors market by revenue share. North America alone has a third of the market in 2017 and is expected to be the only region in the medical X-ray detectors market to record a robust CAGR in excess of 6%. Europe is the second largest region in the fixed detector segment of the medical X-ray detectors market but MEA and Latin America are predicted to grow at a higher CAGR. Portable detectors occupy the balance revenue share in the modality segment of the medical X-ray detectors market. This segment is highly likely to see strong growth and companies can try to target this lucrative segment accordingly.

Large-area flat panel detectors are dominant in the medical X-ray detectors market by panel size segment in 2017 and are estimated to remain so going forward. The large-area flat panel detector segment in both North America and Europe is assessed to be worth more than US$ 600 million by the end of the forecast period, ensuring that all major players can be profitable in such a large market. The small-area flat panel detectors segment is particularly popular in North America with a high CAGR in the APEJ region.

Computed radiography has a revenue share of just over a fifth of the medical X-ray detectors market by product type segment and is likely to lose popularity over the study period. A similar CAGR greater than 4.5% exists in Latin America and APEJ but the latter is considerably larger in terms of market size.

North America is the largest region in the medical X-ray detectors market and the U.S. accounts for the lion’s share within the continent. The U.S. medical X-ray detectors market is anticipated to grow to more than a billion dollars by end 2022.

Request and Download Sample Report@

https://www.persistencemarketresearch.com/samples/18580

The companies profiled in the medical X-ray detectors market report are Teledyne Technologies Incorporated, Rayence Co., KONICA MINOLTA, Hamamatsu Photonics, DRTECH Corporation, Canon Inc, Analogic Corporation, FUJIFILM Holdings Corporation, Onex Corporation, and Agfa-Gevaert N.V.

Buy Full Medical X-ray Detectors Market Report

@ https://www.persistencemarketresearch.com/checkout/18580

Pneumatic Compression Market Will Cross US$ 670 Mn by the end of 2025

The international pneumatic compression therapy market is expected to record a CAGR of 6.6%, and is slated to reach a market value of above US$ 670 million by the end of 2025.

The robust development of the overall therapy market is influenced by the accessibility of substitute therapies, advancement in technology, improved lifestyle, improved reimbursement provisions, increasing occurrences of varicose vein disease and increase in home care devices.

The overall market of the pneumatic compression therapy is segmented into product type, distribution channels and by region.

Browse Full Research Report:

https://www.persistencemarketresearch.com/market-research/pneumatic-compression-therapy-market.asp

Forecast by Product Type:

Based on product type, the market is sub-segmented into

  • Segmented pneumatic compression pumps
  • Non-segmented pneumatic compression pumps
  • Non-programmable pneumatic compression pumps
  • Pneumatic compression sleeves.
  • Programmable pneumatic compression pumps

The pneumatic compression sleeve sector is anticipated to remain lucrative with a desirability index of 1.8 amongst other product type sector. The segment is likely to record a remarkable CAGR of 7.3% during the forecast period. Alternatively, the segmented pneumatic compression pumps sector is likely to remain unprofitable segment with a minimum market desirability index of 0.9 in the overall market.

Forecast by Distribution Channel:

In terms of the distribution channel, the market is sub-segmented into E-commerce, clinics and hospitals. Among other distribution channels, hospitals are likely to be the maximum productive sector with a market desirability index of 1.4. Clinics are predicted to remain the second most lucrative distribution channel with a desirability index of 1.0.

The online distribution channel is also increasingly becoming popular and lucrative owing to offering convenient shopping as it offers products at a cheaper price which is considerably less than the physical stores. Moreover, the physical stores have a restricted selection of products due to space constraints.

Request and Download Sample Report@

https://www.persistencemarketresearch.com/samples/17557

Forecast by Region:

The growth potential of pneumatic compression therapy market in different regions includes Latin America, North America, Asia Pacific, Europe and the Middle East and Africa. North America is projected to grow at a remarkable CAGR of 6.7% as well as a market desirability index of 3.4. Whereas, Europe is likely to remain the second leading region along with a market desirability index of 0.9 in the worldwide market.

The prominent companies in the therapy market include,

  • Bösl Medizintechnik.
  • Devon Medical Products
  • Medtronic
  • XIAMEN SENYANG CO. LTD
  • Bio Compression Systems, Inc.
  • DJO Global, Inc.
  • Tactile Medical
  • Mego Afek Ltd.
  • ArjoHuntleigh
  • Medline Industries, Inc.
  • Talley Group Limited
  • EUREDUC

Buy Full Endodontics Market Report

@ https://www.persistencemarketresearch.com/checkout/17557

Skin Rejuvenation Market Will Cross at a CAGR of 8.7% by the end of 2022

Aging induces various skin related problems o defects such as wrinkles, lines etc. Various medical treatments for curing these disorders are being developed. Skin rejuvenation essentially is improving the skin appearance with the help of advanced medical treatments. Global skin rejuvenation market is influenced by various aspects such as growth in medical science, innovations in various products and enhancement of technology, various manufacturers opting for advanced skin rejuvenation medication therapies, increasing prevalence of skin problems owing to aging coupled with rising consciousness and increasing disposable income of people worldwide, increasing awareness of non-invasive and minimally invasive procedures and increased investment in research and development in the skin care industry by various companies in this sector. However, the main limitation to the growth of this market is the affordability quotient as not all class of people can afford skin rejuvenation medications.

Browse Full Research Report:

https://www.persistencemarketresearch.com/market-research/skin-rejuvenation-market.asp

The extensive research report on “Skin Rejuvenation Market: Global Industry Analysis (2012-2016) and Forecast (2017-2022)” by Persistence Market Research uncovers various aspects of the global skin rejuvenation market with which a future market scenario for skin rejuvenation devices can be drawn that can assist the reader in planning expansion strategies. According to this research study, the global market for skin rejuvenation is projected to register a healthy CAGR of 8.7% throughout the period of assessment to reflect a noteworthy market value.

Request and Download Sample Report@

https://www.persistencemarketresearch.com/samples/19318

4 Key Highlights on Global Skin Rejuvenation Market

  • The global skin rejuvenation market is segmented by product type, by end user and by region.

  • By product type, the global skin rejuvenation market is dominated by IPL devices segment. This segment is a highly lucrative and estimated to be the largest segment in terms of market value and share. By the end of the assessment year, the IPL devices segment is expected to show a high value of a bit over US$ 690 Mn

  • By product type category, the laser based devices market is the fastest growing segment to reach stellar valuation. This segment is rising owing to increased use of laser in skin rejuvenation treatment procedures

  • By end user category, the dermatology clinics segment is the largest segment and is likely to lead the global skin rejuvenation market in terms of market valuation. In 2017, this segment reflected a high market share of more than 60% and is likely to continue to retain its status quo during the assessment period 2017-2022

  • By region, North America and Asia Pacific excluding Japan (APEJ) regions reflect high potential in the years to come. The North America region is expected to dominate the global market by region as it is estimated to be the largest and highly attractive for skin rejuvenation. North America skin rejuvenation market is estimated to reach a noteworthy value growing at the highest 9.4% CAGR during assessment period

  • Key Players Operating in the Global Endodontics Market – Detailed Competitive Assessment

The fact based research report on global skin rejuvenation market covers an in-depth competitive assessment which includes details like SWOT analysis, product portfolio, new developments and innovations and key financials along with company overview of key players such as Cutera Inc., Lutronic Corporation, Syneron Medical Ltd., Strata Skin Sciences, Inc., Cynosure, Inc., Lumenis Ltd., Solta Medical Inc., Lynton Lasers Ltd., EL.En. S.p.A., Sciton, Inc., Fotona d.d. and Alma Lasers, Ltd.

Buy Full Endodontics Market Report

@ https://www.persistencemarketresearch.com/checkout/19318

Flow Cytometry Market Will Cross US$ 63.5 Mn by the end of 2022

Flow cytometry is used to monitor microscopic particles with the help of electronic devices called flow cytometers. Flow cytometry is used in stem cell research, in the development of immunology products and vaccines and also in CD4 testing. The global flow cytometry market is influenced by various factors such as medical and technological developments in flow cytometry products, rising use of flow cytometry in clinical trials, in detection of blood cancer, in research, in launching of new reagents for critical applications such as drug discovery and diagnostics and also in development of intuitive and user-friendly software are fuelling the growth of the flow cytometry market in the forthcoming timeline. Moreover, rising prevalence of AIDS and cancer has triggered the adoption of flow cytometry technology in scientific research. This is supporting the growth of the global flow cytometry market.

Browse Full Research Report:

https://www.futuremarketinsights.com/reports/flow-cytometry-market

The analytical and extensive research report on “Flow Cytometry Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2022)” published by Future Market Insights uncovers various factors of the global market for flow cytometry which can be used to analyse and grasp opportunities in the market across regions worldwide in order to carry out expansion programs in the future. According to the market analysis in this research report, the global flow cytometry market is projected to grow at a VAGR of 7.1% during the period of assessment 2017-2022.

5 Key Highlights on the Global Flow Cytometry Market

  • The global flow cytometry market is segmented by application, end user, technology, product type and region.

  • By application, the research segment is expected to dominate the global market with respect to high market share. By the end of 2022, this segment is estimated to reach a high market valuation of around US$ 1.8 Bn growing at a high CAGR during this period. The industrial segment is projected to grow at the highest rate during the assessment period and poised to gain a high BPS by the end of 2022

  • By technology, the cell based segment is the largest segment. It is projected to grow at a CAGR of 7.2% throughout the period of forecast and is estimated to gain a very high valuation during the period of assessment

  • North America region is a highly lucrative region for the growth of the global flow cytometry market. The market in North America is soaring at a higher pace and expected to surpass other regions

  • By end user, the commercial organizations segment is expected to gain the highest BPS by end of 2022. Moreover, this segment demands increasing use of flow cytometry and is the largest and the fastest growing segment in the flow cytometry market

  • In the product type category, the reagents and consumables have gained high traction in the recent years. This segment is a high contributor of growth of the global flow cytometry market. The reagents and consumables segment is estimated to gain a high BPS and grow at a high CAGR of 7.9% throughout the period of assessment

Global Flow Cytometry Market: Competitive Landscape

The global flow cytometry market research study includes a separate section on competitive landscape in which it focuses on the key players and their in-depth analysis including company overview, SWOT analysis, developments, innovations, key financials and product portfolios. This extensive research report covers key companies such as Miltenyi Biotec GmbH, General Electric Company, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck & Co Inc., Agilent Technologies, Inc., Sysmex Corporation, Becton Dickinson and Company and Danaher Corporation.

Leadless Pacing Systems Market Will Cross US$ 63.5 Mn by the end of 2025

According to the latest market report published by Persistence Market Research titled ‘Leadless Pacing Systems Market: Global Industry Analysis (2012 – 2016) & Forecast (2017 – 2025),’ the market is poised to expand at a CAGR of 10.0% in terms of value over the forecast period (2017–2025). The overall market is anticipated to grow 2.15x in terms of value over the forecast period of 2017–2025. Certain factors such as rise in the number of eligible patients, increasing reimbursement scenario, rising disposable income, preference for new technology, growing geriatric population, rising number of cardiovascular diseases and increasing number of medical insurers is expected to support market growth over the forecast period. Revenue growth is also supported by several technological benefits of leadless pacing systems over traditional pacemaker systems. The report analyzes the leadless pacing systems market in terms of value (US$ Mn) by application type, end user and region. The report also provides information regarding market dynamics, macro-economic factors, opportunity analysis, pricing analysis, regulations, competitive landscape, regional volume analysis, current trends, market estimation and forecast, technology assessment and major deals in the leadless pacing systems market.

Browse Full Research Report:

https://www.persistencemarketresearch.com/market-research/leadless-pacing-system-market.asp

The global leadless pacing systems market is expected to exceed US$ 63.5 Mn by 2025, attesting the highest growth of the atrial fibrillation application segment, which is expected to expand at 10.1% CAGR over the forecast period. Atrial fibrillation segment will dominate the market in terms of value. In the end user segment, hospitals represent more than 85% of the market share.

In terms of value, the North America regional market holds the highest share in the global market followed by Europe. This is because of higher demand in these regions, product affordability and a favorable reimbursement scenario. Middle East & Africa represents a significant market share in the global leadless pacing systems market given the historical acceptance in the number of procedures for leadless pacing technology over traditional pacemakers. In terms of growth rate, Europe leads with a CAGR of 11.2% followed by Asia Pacific with an increasing product acceptance. Latin America is anticipated to have the least market size over the forecast period. The global market for leadless pacing systems is anticipated to expand at a significant growth rate over the forecast period providing good growth opportunities for market players.

Request and Download Sample Report@

https://www.persistencemarketresearch.com/samples/12205

Key Research Findings

  • Demand for leadless pacing systems is anticipated to remain high through 2025, registering a CAGR of 10.0% over the forecast period owing to the rising number of cardiovascular diseases and increasing pacemaker implant rate

  • Due to the technical advantages of leadless pacing systems, this product segment is anticipated to absorb significant market size in the single chamber ventricular pacing systems market

  • The higher pricing of leadless pacing systems than normal pacemakers is a major limiting factor in the leadless pacing systems market

  • There are only two companies with their products commercially approved by regulatory bodies while some other companies have their products still in the development phase. Medtronic plc. is the only company with FDA approval

  • Acquisitions, mergers, expansions, product approvals, product launches and adoption of new technologies are the key strategies adopted by manufacturers and integrators for technology transfer and to increase consumer base in different geographies

  • North America is anticipated to remain the largest consumer base for leadless pacing systems owing to a higher acceptance rate and a favorable reimbursement scenario

  • Several opportunities are available for companies to improve their product penetration such as development of dual chamber and multi chamber pacing, providing professional education & training, distribution reach etc.

Key Players

The report profiles some of the leading players operating in the global leadless pacing systems market such as Abbott Laboratories and Medtronic plc. Boston Scientific Corporation and Biotronik are still in the development phase for leadless pacing systems.

Buy Full Endodontics Market Report

@ https://www.persistencemarketresearch.com/checkout/12205

Endoscopy Equipment Market Will Cross US$33.5 bn by the end of 2022

The global endoscopy equipment market is likely to exhibit stable growth over the coming years due to a steady rise in the application of endoscopy in diverse end use diagnostic fields, the steady product development scenario in the medical devices sector, and the booming healthcare sector in developed economies. The endoscopy equipment market has remained a steady contributor to the global medical devices sector in recent years and is likely to remain relevant to the economic dynamics of the healthcare sector in the coming years due to its strong growth prospects in not just developed regions such as North America and Europe but also several emerging economies in Asia Pacific except Japan.

The global endoscopy equipment market is likely to exhibit a strong 4% CAGR in the 2017-2022 forecast period, rising from a likely 2017-end valuation of US$27.5 bn to US$33.5 bn by the end of 2022. Analysts at Transparency Market Research have attributed the growth of the endoscopy equipment market to a number of factors.

Browse Full Research Report:

https://www.transparencymarketresearch.com/endoscopy-equipment-market.html

The rapid advancement of the medical devices sector and the steady availability of funding for product enhancement is likely to remain the prime driver for the global endoscopy equipment market in the coming years. Product development has become a major strategy for players in the medical devices sector due to the steady availability of technological advances that allow for the production of better products and rising competition in the sector. The endoscopy equipment market is likely to benefit from this trend significantly in the coming years due to the rising number of players looking to carve out a significant share in the market, which has served to boost competition.

The rising prevalence of gastroenterological disorders in developed regions such as North America and Western Europe is likely to be a key driver for the global endoscopy equipment market in the coming years. Gastroenterology is the leading application of endoscopy equipment and has gained increased demand due to the growing adoption of unhealthy dietary and lifestyle choices, including the increasing preference to addictions such as tobacco and alcohol. Endoscopy plays a key role in the diagnosis of gastric problems and is the established means of diagnosis for several gastric disorders, ensuring steady growth of the endoscopy equipment market in the coming years.

The rapid growth of the healthcare sector in developing economies in Asia Pacific except Japan (APEJ) is likely to be a major driver for the global endoscopy equipment market in the coming years. The APEJ market for endoscopy equipment is likely to exhibit a strong 4.1% CAGR over the 2017-2022 forecast period, enabling a steady rise of the regional market to a valuation of more than US$7.5 bn by the end of 2022. Countries such as China, Korea, Taiwan, Indonesia, Malaysia, and India are likely to be crucial to the endoscopy equipment market in the coming years due to the growing adoption of Western lifestyles in the region and growing government support to advancement of the healthcare and medical devices sector.

Leading players in the increasingly competitive global endoscopy equipment market include Arthrex Inc., Stryker Corporation, B. Braun Melsungen AG, Boston Scientific Corporation, Olympus Corporation, Cook Medical Inc., Karl Storz GmbH & Co. KG, Smith & Nephew Plc, Fujifilm Holdings Corporation, and Medtronic Plc.

 

Spinal Fusion Market Pegged to Reach US$ 12,561.9 Mn by the end of 2027

Future Market Insights (FMI) delivers key insights on the global spinal fusion market in its upcoming report titled “Spinal Fusion Market: Global Industry Analysis 2012–2016 and Opportunity Assessment 2017 – 2027.” In terms of revenue, the global spinal fusion market is projected to register a CAGR of 5.4% over the forecast period, owing to various factors, regarding which FMI offers detailed insights and forecasts in this report. A key trend witnessed in the global spinal fusion market is the rise in the development of minimising load due to increasing adverse reactions. Furthermore, the growing importance of developing advanced products among big players to enhance their product portfolio is another key trend in the global spinal fusion market.

Market Segmentation and Forecast

The global spinal fusion market is segmented based on product type, procedure type, end user and region. Based on product type, the market is segmented into interbody cages, pedicle screws and rods, and spinal fusion plates. Interbody cages is predicted to be the leading product type segment in the global spinal fusion market over the forecast period. Attenuated interbody cages segment will represent major revenue share of the global spinal fusion market in 2017.  By procedure, the global spinal fusion market is segmented into posterolateral fusion and interbody fusion. Interbody fusion is the leading segment in the global spinal fusion market over the forecast period. By end user, the global spinal fusion market is segmented into hospitals, speciality clinics and ambulatory surgical centres. Hospitals is the leading segment in the global spinal fusion market over the forecast period. Demand for spinal fusion is expected to be the highest in ambulatory surgical centres, which is expected to register a CAGR of 6.6 % over the forecast period.

This report assesses the trends that are driving the growth of each segment at the global as well as regional level, and offers potential takeaways that could prove substantially useful to manufacturers looking to enter the market. North America is expected to gain popularity over the forecast period, driven by increasing prevalence of spinal injuries across the region. The North America regional market is projected to dominate the global spinal fusion market, accounting for a maximum revenue share of the global market by 2017 end. The markets in North America, Western Europe, and Asia Pacific are collectively expected to account for around 68.6% of the global spinal fusion market value share by 2017 end. Revenue from the market in APEJ is estimated to expand at a CAGR of 8.9% over the forecast period.

Key Players

Some of the leading market players covered in the report include Zimmer Biomet Holdings. Inc., K2M, Inc., MicroPort Scientific Corporation, Medtronic Plc., Johnson and Johnson (DePuy Synthes), Stryker Corporation, Integra Lifesciences Holdings Corp, Orthofix Holdings, Inc., Shandong Weigao Group Medical Polymer Company Limited, Bonovo Orthopedics, Inc., Suzhou Gemmed Medical Instrument Co. Ltd, NuVasive, Inc., B. Braun Melsungen AG, Globus Medical Inc., RTI Surgical, Inc., Expanding Orthopedics Inc., Vallum Corporation, ChoiceSpine, LP, Life Spine, Inc, and Precision Spine, Inc. In this report, we have discussed the individual strategies followed by these companies regarding bringing improvements in their products, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The report concludes with key takeaways for players already present in the market and new players planning to enter the market.

Browse Full Research Report Herehttps://www.futuremarketinsights.com/reports/global-spinal-fusion-market